Literature DB >> 8546898

Multiple regions of chromosome 6q affected by loss of heterozygosity in primary human breast carcinomas.

Z M Sheng1, A Marchetti, F Buttitta, M H Champeme, D Campani, M Bistocchi, R Lidereau, R Callahan.   

Abstract

A total of 80 primary human breast carcinoma DNAs were analysed for loss of heterozygosity (LOH) on the long arm of chromosome 6, using microsatellite markers whose location has been defined physically and by linkage analysis. Loss of heterozygosity was observed in 38 of 80 (48%) tumours that were informative for at least one locus. The analysis revealed partial or interstitial deletions of chromosome 6q. Detailed mapping of chromosome 6q in these tumour DNAs identified two and perhaps three commonly deleted regions. One of these is located between markers D6S251 and D6S252 (6q14-q16.2), another between D6S268 and D6S261 (6q16.3-q23) and a third between D6S287 and D6S270 (6q22.3-q23.1).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8546898      PMCID: PMC2074311          DOI: 10.1038/bjc.1996.27

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  The 1993-94 Généthon human genetic linkage map.

Authors:  G Gyapay; J Morissette; A Vignal; C Dib; C Fizames; P Millasseau; S Marc; G Bernardi; M Lathrop; J Weissenbach
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

Review 2.  Cytogenetic and molecular biologic alterations in human breast cancer: a review.

Authors:  J M Trent
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

3.  Report of the Second International Workshop on Human Chromosome 6.

Authors:  A Volz; J M Boyle; H M Cann; R W Cottingham; H T Orr; A Ziegler
Journal:  Genomics       Date:  1994-05-15       Impact factor: 5.736

4.  Questions about adolescent gestational age and birth weight.

Authors:  J M Rees; C M Bach
Journal:  Pediatrics       Date:  1994-08       Impact factor: 7.124

5.  Clonal chromosome abnormalities in human breast carcinomas. II. Thirty-four cases with metastatic disease.

Authors:  J Trent; J M Yang; J Emerson; W Dalton; D McGee; K Massey; F Thompson; H Villar
Journal:  Genes Chromosomes Cancer       Date:  1993-08       Impact factor: 5.006

Review 6.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

Review 7.  Genetic and molecular heterogeneity of breast cancer cells.

Authors:  R Callahan; C Cropp; G R Merlo; F Diella; T Venesio; R Lidereau; A P Cappa; D S Lisicia
Journal:  Clin Chim Acta       Date:  1993-07-30       Impact factor: 3.786

8.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.

Authors:  S H Friend; R Bernards; S Rogelj; R A Weinberg; J M Rapaport; D M Albert; T P Dryja
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

Review 9.  The ninth Gordon Hamilton-Fairley memorial lecture. Hereditary cancers: clues to mechanisms of carcinogenesis.

Authors:  A G Knudson
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

10.  Proximal 6q, a region showing allele loss in primary breast cancer.

Authors:  V Orphanos; G McGown; Y Hey; J M Boyle; M Santibanez-Koref
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640

View more
  22 in total

1.  Physical localisation of the breakpoints of a constitutional translocation t(5;6)(q21;q21) in a child with bilateral Wilms' tumour.

Authors:  P R Hoban; R L Cowen; E L Mitchell; D G Evans; M Kelly; P J Howard; J Heighway
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

2.  Parkin gene alterations in ovarian carcinoma from northern Indian population.

Authors:  Syed Jafar Mehdi; Asgar Ali; M Moshahid Alam Rizvi
Journal:  Pathol Oncol Res       Date:  2011-01-10       Impact factor: 3.201

3.  Allelic loss of 6q25-27, the PARKIN tumor suppressor gene locus, in cervical carcinoma.

Authors:  S J Mehdi; M S Alam; S Batra; M M A Rizvi
Journal:  Med Oncol       Date:  2010-07-22       Impact factor: 3.064

4.  Undetectable and Decreased Expression of KIAA1949 (Phostensin) Encoded on Chromosome 6p21.33 in Human Breast Cancers Revealed by Transcriptome Analysis.

Authors:  Yan A Su; Jun Yang; Lian Tao; Hein Nguyen; Ping He
Journal:  J Cancer       Date:  2010-06-21       Impact factor: 4.207

5.  Characterization of mice deficient in the Src family nonreceptor tyrosine kinase Frk/rak.

Authors:  Subhashini Chandrasekharan; Ting Hu Qiu; Nawal Alkharouf; Kelly Brantley; James B Mitchell; Edison T Liu
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

Review 6.  RAKing in AKT: a tumor suppressor function for the intracellular tyrosine kinase FRK.

Authors:  Patrick M Brauer; Angela L Tyner
Journal:  Cell Cycle       Date:  2009-09-29       Impact factor: 4.534

7.  Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse.

Authors:  Michael J Campbell; Wendy S Wollish; Margaret Lobo; Laura J Esserman
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-06       Impact factor: 2.416

8.  Loss of imprinting of IGF2 and H19, loss of heterozygosity of IGF2R and CTCF, and Helicobacter pylori infection in laryngeal squamous cell carcinoma.

Authors:  Ivana Grbesa; Marino Marinkovic; Mirko Ivkic; Bozo Kruslin; Renata Novak-Kujundzic; Boris Pegan; Ozren Bogdanovic; Vladimir Bedekovic; Koraljka Gall-Troselj
Journal:  J Mol Med (Berl)       Date:  2008-07-05       Impact factor: 4.599

9.  Rak functions as a tumor suppressor by regulating PTEN protein stability and function.

Authors:  Eun-Kyoung Yim; Guang Peng; Hui Dai; Ruozhen Hu; Kaiyi Li; Yiling Lu; Gordon B Mills; Funda Meric-Bernstam; Bryan T Hennessy; Rolf J Craven; Shiaw-Yih Lin
Journal:  Cancer Cell       Date:  2009-04-07       Impact factor: 31.743

10.  Implication of snoRNA U50 in human breast cancer.

Authors:  Xue-Yuan Dong; Peng Guo; Jeff Boyd; Xiaodong Sun; Qunna Li; Wei Zhou; Jin-Tang Dong
Journal:  J Genet Genomics       Date:  2009-08       Impact factor: 4.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.